Suppression of p53-mediated growth factor withdrawal-induced apoptosis in the myeloid compartment by hematopoietic cytokines: An overview of hematopoiesis and apoptosis with a presentation of thrombopoietin and the M07E cell line as a model system

Alec Ritchie, Hal Broxmeyer

Research output: Contribution to journalArticle

8 Citations (Scopus)
Original languageEnglish
Pages (from-to)169-191
Number of pages23
JournalCritical Reviews in Oncology/Hematology
Volume31
Issue number3
DOIs
StatePublished - Aug 1999

Fingerprint

Growth Substances
Cultured Tumor Cells
Thrombopoietin
Tumor Suppressor Protein p53
Hematopoiesis
Hematopoietic Stem Cells
Intercellular Signaling Peptides and Proteins
Apoptosis
Cytokines
Cell Line

ASJC Scopus subject areas

  • Cancer Research
  • Hematology
  • Oncology

Cite this

@article{a1ef00eb20f741a6b29d1e28748316fd,
title = "Suppression of p53-mediated growth factor withdrawal-induced apoptosis in the myeloid compartment by hematopoietic cytokines: An overview of hematopoiesis and apoptosis with a presentation of thrombopoietin and the M07E cell line as a model system",
author = "Alec Ritchie and Hal Broxmeyer",
year = "1999",
month = "8",
doi = "10.1016/S1040-8428(99)00018-9",
language = "English",
volume = "31",
pages = "169--191",
journal = "Critical Reviews in Oncology/Hematology",
issn = "1040-8428",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Suppression of p53-mediated growth factor withdrawal-induced apoptosis in the myeloid compartment by hematopoietic cytokines

T2 - An overview of hematopoiesis and apoptosis with a presentation of thrombopoietin and the M07E cell line as a model system

AU - Ritchie, Alec

AU - Broxmeyer, Hal

PY - 1999/8

Y1 - 1999/8

UR - http://www.scopus.com/inward/record.url?scp=0032859258&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032859258&partnerID=8YFLogxK

U2 - 10.1016/S1040-8428(99)00018-9

DO - 10.1016/S1040-8428(99)00018-9

M3 - Article

C2 - 10532194

AN - SCOPUS:0032859258

VL - 31

SP - 169

EP - 191

JO - Critical Reviews in Oncology/Hematology

JF - Critical Reviews in Oncology/Hematology

SN - 1040-8428

IS - 3

ER -